SGH
IONS icon

Schonfeld Group Holdings’s Ionis Pharmaceuticals IONS Stock Holding History

Schonfeld Group Holdings’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-17,793
Closed -$769K – 192
2014
Q1 		$769K Buy
17,793
+12,155
+216% +$589K 0.19% 142
2013
Q4 		$225K Buy
+5,638
New +$201K 0.09% 320

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Schonfeld Group Holdings's IONS Position: Q2 2014 in Review

Schonfeld Group Holdings sold out of Ionis Pharmaceuticals (IONS) in Q2 2014, closing a stake of 17,793 shares — an estimated $769K sold.

Schonfeld Group Holdings first reported a position in IONS in Q4 2013 and held it in 2 quarters. The position peaked at $769K in Q1 2014. 238 funds tracked by Wall St. Rank hold IONS as of Q2 2014.

  • Schonfeld Group Holdings reported no remaining Ionis Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Schonfeld Group Holdings sold 17,793 Ionis Pharmaceuticals shares in Q2 2014, an estimated $769K.
  • Schonfeld Group Holdings first reported a position in Ionis Pharmaceuticals in Q4 2013 and held it in 2 quarters.
  • Schonfeld Group Holdings's Ionis Pharmaceuticals position peaked at $769K in Q1 2014.
  • 238 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2014.

Based on Schonfeld Group Holdings's 13F filing for Q2 2014, filed 15 Aug 2014.